Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection-Reference-Cited by-同舟云学术

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection

Published:2010-07 Issue:31 Volume:28 Page:5135-5144
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Cummings James F.,Spring Michele D.,Schwenk Robert J.,Ockenhouse Christian F.,Kester Kent E.,Polhemus Mark E.,Walsh Douglas S.,Yoon In-Kyu,Prosperi Christine,Juompan Laure Y.,Lanar David E.,Krzych Urszula,Hall B. Ted,Ware Lisa A.,Stewart V. Ann,Williams Jack,Dowler Megan,Nielsen Robin K.,Hillier Collette J.,Giersing Birgitte K.,Dubovsky Filip,Malkin Elissa,Tucker Kathryn,Dubois Marie-Claude,Cohen Joe D.,Ballou W. Ripley,Jr D. Gray Heppner

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic;Connelly;Infect Immun,1997

2. Factors influencing resistance to reinfection with Plasmodium falciparum;Domarle;Am J Trop Med Hyg,1999

3. Molecular analysis of the association of HLA-B53 and resistance to severe malaria;Hill;Nature,1992

4. Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria;John;Infect Immun,2004

5. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum;Kurtis;Infect Immun,1999

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults;Vaccine;2024-04

2. Malaria Vaccines;Infectious Diseases;2023

3. Malaria Vaccines;Plotkin's Vaccines;2023

4. Controlled Human Infection Models To Accelerate Vaccine Development;Clinical Microbiology Reviews;2022-09-21

5. Malaria Vaccines;Encyclopedia of Sustainability Science and Technology;2022